Study on Outcomes of Proximal Humerus Fractures
Review of Proximal Humerus Fracture Outcomes
1 other identifier
interventional
100
1 country
1
Brief Summary
Patients undergoing either operative or non-operative treatment of proximal humerus fractures will be studied with the goal of understanding which treatment modality provides optimal post-injury outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2025
CompletedFirst Posted
Study publicly available on registry
July 11, 2025
CompletedStudy Start
First participant enrolled
September 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2028
Study Completion
Last participant's last visit for all outcomes
July 1, 2028
October 20, 2025
October 1, 2025
1.7 years
June 29, 2025
October 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Range of Motion (ROM)
Range of Motion of the shoulder in terms of degrees of motion Assessment of forward flexion (0-180 degrees), abduction (0-90 degrees), external rotation (0-90 degrees)
at 3 months, 6 months, 12 months, and 24 months from initiation of treatment
SANE
"Sane outcome" typically refers to the Single Assessment Numeric Evaluation (SANE) score, a patient-reported outcome measure used in healthcare, particularly in orthopedics. It assesses a patient's perceived function of a joint or body region by asking them to rate it on a scale of 0 to 100, where 100 represents normal function
at 3 months, 6 months, 12 months, and 24 months following initiation of treatment
VAS
"VAS outcome" refers to the results obtained from using a Visual Analog Scale (VAS). The VAS is a measurement tool, typically a 10 cm or 100 mm line, where individuals indicate the intensity of a subjective experience, such as pain, by marking a point on the line. The distance from one end of the line to the patient's mark is then measured, and this measurement represents the VAS score. A higher score indicates a greater intensity of the experience being measured.
at 3 months, 6 months, 12 months, and 24 months following initiation of intervention
ASES
The American Shoulder and Elbow Surgeons scale (ASES) is a condition-specific scale that is intended to measure functional limitations and pain of the shoulder. A higher ASES score indicates better shoulder function and less pain, with a score of 100 representing the best possible outcome and a score of 0 representing the worst possible outcome.
at 3 months, 6 months, 12 months, and 24 months following initiation of intervention
EQ-5D-5L
The EQ-5D-5L score represents a patient's self-reported health status, with values ranging from -0.59 to 1, where 1 indicates the best possible health. It's based on five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with five levels of severity. These responses are converted into a single index score using a scoring algorithm.
at baseline and subsequently at 3 months, 6 months, 12 months, and 24 months following initiation of intervention
Brophy/Marx
The Brophy-Marx Shoulder Activity Score is a valid and reliable shoulder-specific questionnaire that measures a patient's shoulder activity level over the previous year. The questionnaire generates a numeric score from 0 (least active) to 20 (most active).
at baseline and subsequently at 12 months and 24 months after initiation of intervention
PROMIS Social
PROMIS, or the Patient-Reported Outcomes Measurement Information System, uses T-scores to represent social health, with a mean of 50 and a standard deviation of 10 for the general US population. Higher T-scores generally indicate a greater amount of the measured concept, such as satisfaction with social roles and activities, while lower scores indicate less.
at 3 months, 12 months, and 24 months following initiation of intervention
Radiographic Outcome
evidence of bony healing, nonunion, or malunion of the fracture on imaging
at 3 months, 6 months, 12 months, and 24 months following initiation of intervention
Complication Rate
Rate of complications following initiation of management
at 3 months, 6 months, 12 months, and 24 months following initiation of intervention
Study Arms (2)
Operative Management
ACTIVE COMPARATORNon-operative Management
NO INTERVENTIONInterventions
treatment with open reduction and plates/screws
open reduction and intramedullary nail
reverse total shoulder arthroplasty
Eligibility Criteria
You may qualify if:
- individuals 65 years of age or older with proximal humerus fractures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UMass Chan Medical School
Worcester, Massachusetts, 01605, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wayne Chan, MD
UMass Chan Medical School
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 29, 2025
First Posted
July 11, 2025
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
July 1, 2028
Last Updated
October 20, 2025
Record last verified: 2025-10